Injection Site Irritation
13
0
0
8
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
15.4%
2 terminated out of 13 trials
80.0%
-6.5% vs benchmark
23%
3 trials in Phase 3/4
25%
2 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (13)
Ondansetron as a Strategy for Reducing Propofol Injection Pain in Pediatrics: a Randomized Controlled Trial
Topical Ice-therapy for Intravitreal Injections
Lidocaine, Esmolol, or Placebo to Relieve IV Propofol Pain
Virtual Reality, Ice Application and Self-injection and Self-test Fair, Pain and State Anxiety
Valsalva Manoeuvre and Intravenous Dexmedetomidine on Attenuating Pain During Propofol Injection in Upper GIT Endoscopy
Sorrel 25R Injector - Sorrel Clinical Study Protocol
Comparison of Subcutaneous Injection of Normal Saline and Bacteriostatic Saline
Effects of Cyclooxygenase (COX) 1-2 Inhibitors on Prevention of Rocuronium Injection Pain
Assessment of Pain on Propofol Injection.
Warm Patch Decrease Propofol Injection Pain
Effect of Esmolol on Pain Due to Rocuronium
A Warmer Temperature Decrease Propofol Injection Pain
The Prevention of Pain Associated With Rocuronium Injection